
McKesson (MCK) Stock Forecast & Price Target
McKesson (MCK) Analyst Ratings
Bulls say
McKesson is a strong player in the pharmaceutical distribution industry, with a successful track record and plans for sustained growth. The company's focus on sustainability and innovation, as well as its expansion into Canada, provides a strong foundation for future success. However, it also faces potential risks such as declining revenue and potential legislation changes, which must be carefully monitored. Nevertheless, McKesson's solid financials and strategic investments make it an attractive choice for investors with a positive long-term outlook.
Bears say
McKesson is expected to overcome its RxTS challenges and boost revenue through its strong performance in the GLP-1 market and contributions from the growing demand for generics. However, sustainability challenges in opioid distribution and human capital management pose significant risks for the company. Despite these risks, strategic initiatives, and strong leadership are expected to result in high returns for investors as the company plans to expand their services and technology solutions in the healthcare industry, with a focus on higher-growth opportunities in the oncology sector.
This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.
McKesson (MCK) Analyst Forecast & Price Prediction
Start investing in McKesson (MCK)
Order type
Buy in
Order amount
Est. shares
0 shares